Ligand Pharmaceuticals | LGND - Equity Capital And Reserves

Stock Price
194.00
Daily Change
2.31 1.21%
Monthly
-2.98%
Yearly
68.42%
Q1 Forecast
186.18

Ligand Pharmaceuticals reported $950.17M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Amgen USD 9.62B 2.19B Sep/2025
Arrowhead Research USD 568.42M 102.37M Dec/2025
Baxter International USD 7.24B 79M Sep/2025
Bristol-Myers Squibb USD 18.55B 1.06B Sep/2025
Eli Lilly USD 23.79B 5.52B Sep/2025
Gilead Sciences USD 21.46B 1.78B Sep/2025
GlaxoSmithKline GBP 16.38B 229M Dec/2025
Glaxosmithkline GBP 21.7B 7.35B Sep/2025
Insmed USD 945.57M 304.16M Sep/2025
Ionis Pharmaceuticals USD 617.97M 13.76M Sep/2025
Ligand Pharmaceuticals USD 950.17M 121.64M Sep/2025
MacroGenics USD 67M 20.38M Sep/2025
Merck USD 51.85B 2.79B Sep/2025
Pacira USD 727.21M 30.55M Sep/2025
Pfizer USD 92.8B 4.11B Sep/2025
Veracyte USD 1.26B 36.61M Sep/2025